Ashwagandha and Immune Function: The Evidence

Ashwagandha and Immunity is a topic that sits at the intersection of stress biology and immune resilience. While ashwagandha (Withania somnifera) is best known for its calming effects, its potential influence on immune function deserves a closer look. In this article, we examine what the human evidence actually says—and what it doesn't—about this adaptogen and the immune system.

The Evidence Base

Before diving into mechanisms, let's be clear about what exists. The provided human trial literature on ashwagandha focuses primarily on stress, anxiety, sleep, muscle strength, and cognitive function. None of the cited studies directly measure immune endpoints such as cytokine profiles, antibody titers, or infection rates. This is a critical starting point.

Chandrasekhar et al. (2012) conducted a randomized, double-blind, placebo-controlled trial (RCT) in 64 adults with chronic stress. Participants received 300 mg of a high-concentration full-spectrum ashwagandha root extract twice daily for 60 days. The study measured serum cortisol, perceived stress, and anxiety scores—not immune markers. Langade et al. (2019) similarly examined insomnia and anxiety in a double-blind RCT using 300 mg twice daily, with outcomes focused on sleep quality and anxiety reduction. Wankhede et al. (2015) studied muscle strength and recovery in healthy men using 300 mg twice daily of root extract. Choudhary et al. (2017) evaluated cognitive function with 300 mg twice daily. Pratte et al. (2014) published a systematic review of human trials for anxiety, again with no immune data.

What does this mean? Direct human evidence linking ashwagandha to immune enhancement is currently absent from this body of literature. Any immune-related claims must be inferred from stress-cortisol pathways or extrapolated from preclinical (animal and cell) research not represented in these citations. We will address this honestly.

Study	Design	Dose & Form	Population	Primary Outcomes	Immune Data
Chandrasekhar et al. (2012)	RCT, double-blind, placebo-controlled	300 mg × 2/day, full-spectrum root extract	64 adults with chronic stress	Cortisol, perceived stress, anxiety	None
Langade et al. (2019)	RCT, double-blind, placebo-controlled	300 mg × 2/day, root extract	Adults with insomnia and anxiety	Sleep quality, anxiety scores	None
Wankhede et al. (2015)	RCT, double-blind, placebo-controlled	300 mg × 2/day, root extract	Healthy men, muscle training	Muscle strength, recovery	None
Choudhary et al. (2017)	RCT, double-blind, placebo-controlled	300 mg × 2/day, root extract	Healthy adults	Memory, cognitive function	None
Pratte et al. (2014)	Systematic review of human trials	Varied (mostly 300–600 mg/day)	Adults with anxiety	Anxiety reduction	None

The Mechanism: Stress, Cortisol, and Immune Crosstalk

While direct immune studies are lacking in the human literature provided, the stress-immune axis offers a plausible mechanistic bridge. Chronic psychological stress is well-documented to suppress immune function through elevated cortisol. Cortisol, a glucocorticoid hormone released by the HPA axis, exerts broad immunosuppressive effects: it reduces lymphocyte proliferation, dampens cytokine production (particularly IL-2 and IFN-γ), and shifts immune responses toward a Th2-dominant profile.

Ashwagandha's most consistent effect in human trials is cortisol reduction. Chandrasekhar et al. (2012) reported that 600 mg/day of full-spectrum root extract reduced serum cortisol by approximately 27.9% compared to placebo after 60 days. This finding is relevant because lower cortisol, in theory, removes a brake on immune cell activity. However, this is an inference, not a measured outcome. No immune cell counts or functional assays were performed. For a deeper look at the HPA axis mechanism, see our article on How Ashwagandha Lowers Cortisol: The HPA Axis Mechanism.

Preclinical research (not cited here but widely published) suggests that Withania somnifera contains withanolides, including withaferin A, which modulate NF-κB signaling and may influence macrophage activity and cytokine production in vitro. Human translation of these findings remains unverified. Animal studies showing enhanced natural killer cell activity and improved antibody response exist, but human data is limited. We cannot responsibly extend these findings to people without reservation.

What the Evidence Does Not Show

It is equally important to clarify what ashwagandha has not been proven to do for immunity in humans. The studies provided do not demonstrate:

• Reduced incidence or severity of infections (colds, flu, or other)
• Enhanced vaccine antibody response
• Modulation of specific immune cell populations (T cells, B cells, NK cells)
• Altered inflammatory cytokine profiles (IL-6, TNF-α, CRP)
• Benefit in autoimmune or immunodeficiency conditions

Pratte et al. (2014), in their systematic review of ashwagandha for anxiety, noted that the overall quality of human trials was moderate, with small sample sizes and short durations. This limitation applies to any extrapolation: if the primary outcome literature is still evolving, derivative claims about immune function carry even less certainty.

Some supplement marketing conflates adaptogen use with "immune boosting." This is misleading. Adaptogens, as explained in our Adaptogens Explained: What They Are and What the Evidence Says article, are compounds that may help the body adapt to stress. Stress reduction and immune enhancement are related but distinct concepts. One does not automatically imply the other.

Who Benefits Most

Based on the available human evidence, the populations with the strongest rationale for ashwagandha use are those with stress-related symptom burden, not necessarily those seeking immune support. Chandrasekhar et al. (2012) showed benefit in adults with chronic stress. Langade et al. (2019) demonstrated improved sleep in those with insomnia. Wankhede et al. (2015) found enhanced muscle recovery in trained men, which may indirectly relate to immune resilience through reduced exercise-induced immunosuppression.

Who might see immune-related benefit, if any? Theoretical candidates include:

• Individuals with chronically elevated cortisol due to psychological stress, where cortisol normalization might restore immune homeostasis
• Athletes undergoing heavy training, given the known link between overtraining, cortisol, and upper respiratory tract infections
• Older adults experiencing stress-related sleep disruption, since sleep quality independently modulates immune function

Even for these groups, the immune benefit is speculative. Choudhary et al. (2017) showed cognitive improvements in healthy adults, but cognition and immunity, while both affected by stress, are separate physiological systems. We should not assume crossover effects without data.

For those interested in ashwagandha's broader physiological effects, including its potential role in inflammatory modulation, see our analysis of Ashwagandha and Inflammation: What the Research Shows.

Form, Dose, and Practical Considerations

The studies cited consistently used 300 mg of root extract twice daily (600 mg/day total), typically standardized to a withanolide content. This is the best-supported dosing regimen in the human literature for stress and anxiety outcomes. Wankhede et al. (2015) used the same dose for muscle strength. There is no established "immune dose" because immune endpoints have not been tested.

Form matters. The studies used full-spectrum or concentrated root extracts, not raw powder. Standardization to withanolide content (typically 2.5–5%) is common in research-grade materials. KSM-66 is a specific full-spectrum extract used in several trials, though not all cited studies specify the extract type. For those selecting a supplement, a standardized root extract with documented withanolide content aligns most closely with the research. Bio:sudo KSM-66 Reishi Restore combines this extract with reishi mushroom, another traditional adaptogen, though the combination itself has not been studied in the trials cited here.

Safety data from the provided studies is reassuring. Chandrasekhar et al. (2012) and Langade et al. (2019) reported no serious adverse events at 600 mg/day. Mild gastrointestinal symptoms were occasionally noted. However, long-term safety data beyond a few months is limited. Ashwagandha may interact with thyroid medications, sedatives, and immunosuppressants—consult a clinician if you fall into these categories.

Practical Takeaways

• Human evidence directly linking ashwagandha to immune enhancement is currently absent. Do not expect immune "boosting" based on the available RCT literature.
• The stress-cortisol pathway is the most plausible mechanism for any indirect immune benefit, but it remains theoretical in humans.
• 600 mg/day of standardized root extract is the most studied dose for stress and sleep outcomes, with no established immune-specific dose.
• Chronically stressed individuals, poor sleepers, and heavy-training athletes have the strongest evidence base for ashwagandha use, though immune effects are inferred, not proven.
• Do not replace proven immune strategies (vaccination, sleep hygiene, nutrition, exercise) with ashwagandha supplementation.
• Choose standardized extracts with documented withanolide content if you decide to try ashwagandha. Raw powder quality is highly variable.

Bottom Line

Ashwagandha has a solid, if modest, evidence base for stress reduction and cortisol lowering in humans. Whether this translates to meaningful immune benefit remains unproven in clinical trials. The mechanism is plausible, but plausibility is not proof. If you are considering ashwagandha for immune support, manage expectations accordingly—and prioritize the interventions with actual evidence.

References

1. Chandrasekhar K, et al. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults." Indian Journal of Psychological Medicine. 2012;34(3):255–262. [Source]
2. Langade D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety." Medicine. 2019;98(37):e17186. [Source]
3. Wankhede S, et al. "Examining the effect of Withania somnifera supplementation on muscle strength and recovery." Journal of the International Society of Sports Nutrition. 2015;12:43. [Source]
4. Choudhary D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in improving memory and cognitive functions." Journal of Dietary Supplements. 2017;14(6):599–612. [Source]
5. Pratte MA, et al. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha." Journal of Alternative and Complementary Medicine. 2014;20(12):901–908. [Source]

---

---